BBOTVSBTAI• 6 Months (Normalized)
BBOT vs BTAI (BridgeBio Oncology Therapeutics Inc. vs BioXcel Therapeutics Inc.)
Showing Closing Date Range from Apr 8 to Oct 5, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BBOT Performance $3.6
-58.33%
BridgeBio Oncology Therapeutics Inc.
Normalized Baseline0.00%
BTAI Performance $0.04
+%
BioXcel Therapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin BTAI LEADS
-58.33 pts
BTAI outperforming by 58.33 percentage points
BBOTBTAI
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BBOT BTAI
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(124 dates)
| Date | BBOT Price | BBOT Gain (%) | BTAI Price | BTAI Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 05, 2026 | $3.60 | -58.33% | $- | - | |
| Oct 02, 2026 | $3.89 | -54.98% | $- | - | |
| Sep 30, 2026 | $4.10 | -52.55% | $- | - | |
| Sep 29, 2026 | $3.92 | -54.63% | $- | - | |
| Sep 28, 2026 | $3.81 | -55.90% | $- | - | |
| Sep 25, 2026 | $3.95 | -54.28% | $- | - | |
| Sep 24, 2026 | $3.99 | -53.82% | $0.04 | -96.79% | +42.97% |
| Sep 23, 2026 | $4.16 | -51.85% | $0.05 | -95.91% | +44.06% |
| Sep 22, 2026 | $4.66 | -46.06% | $0.04 | -95.95% | +49.89% |
| Sep 21, 2026 | $4.66 | -46.06% | $0.06 | -94.41% | +48.35% |
| Sep 18, 2026 | $4.77 | -44.79% | $0.06 | -94.73% | +49.94% |
| Sep 17, 2026 | $4.89 | -43.40% | $0.08 | -93.17% | +49.77% |
| Sep 16, 2026 | $4.76 | -44.91% | $0.07 | -93.92% | +49.01% |
| Sep 15, 2026 | $4.88 | -43.52% | $0.04 | -95.94% | +52.42% |
| Sep 14, 2026 | $5.05 | -41.55% | $0.05 | -95.90% | +54.35% |
Page 1 of 9